Literature DB >> 16933096

Percolative transport and cluster diffusion near and below the percolation threshold of a porous polymeric matrix.

Jayne E Hastedt1, James L Wright.   

Abstract

PURPOSE: The purpose of this research was to develop a quantitative mass transport model to describe the release of a drug from a porous inert matrix dosage form near and below the percolation threshold for the system.
METHODS: Cumulative release profiles were generated for a series of tablets composed of a binary mixture of varying amounts of non-conducting (poly(vinyl stearate)) and conducting (benzoic acid) components. The porous microstructure was analyzed using re-constructed three-dimensional images of leached microtomed tablet sections. Poly(vinyl stearate) was characterized for transport properties, molecular weight and thermal properties.
RESULTS: Based on percolation theory, the binary matrix was determined to have a percolation threshold of 0.09 +/- 0.02. Transport, which could not be explained by "classical" percolation theory or surface diffusion alone, was observed below the percolation threshold for the system.
CONCLUSIONS: A model describing transport near and below the percolation threshold in matrices composed of two phases, polymer and drug, was developed. The percolation model developed accounts for diffusion within the porous structure and through the inert, insoluble polymeric amorphous regions of the matrix. The low percolation threshold and subsequently high coordination was concluded to be due to the biphasic classical porous and nonclassical polymeric diffusional transport mechanisms associated with the system studied.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16933096     DOI: 10.1007/s11095-006-9072-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

Review 1.  New trends in the production of pharmaceutical granules: the classical batch concept and the problem of scale-up.

Authors:  H Leuenberger
Journal:  Eur J Pharm Biopharm       Date:  2001-11       Impact factor: 5.571

2.  Validation study of the conductometrical analysis. Application to the drug release studies from controlled release systems.

Authors:  I Caraballo; J Alvarez-Fuentes; L M Melgoza; M Millán; M A Holgado; A M Rabasco; M Fernández-Arévalo
Journal:  J Pharm Biomed Anal       Date:  1998-10       Impact factor: 3.935

3.  Estimation of the percolation thresholds in dextromethorphan hydrobromide matrices.

Authors:  L M Melgoza; A M Rabasco; H Sandoval; I Caraballo
Journal:  Eur J Pharm Sci       Date:  2001-02       Impact factor: 4.384

Review 4.  Percolation thresholds in ultrasound compacted tablets.

Authors:  I Caraballo; M Millán; A Fini; L Rodriguez; C Cavallari
Journal:  J Control Release       Date:  2000-12-03       Impact factor: 9.776

5.  Electrodynamic investigations of conduction processes in humid microcrystalline cellulose tablets.

Authors:  Martin Nilsson; Maria Strømme
Journal:  J Phys Chem B       Date:  2005-03-31       Impact factor: 2.991

6.  The use of additives to modulate the release of a sparingly water soluble drug entrapped in PLA50 microparticles.

Authors:  C Mallard; J Coudane; I Rault; M Vert
Journal:  J Microencapsul       Date:  2000 Jan-Feb       Impact factor: 3.142

7.  Properties of hot-melt extruded theophylline tablets containing poly(vinyl acetate).

Authors:  F Zhang; J W McGinity
Journal:  Drug Dev Ind Pharm       Date:  2000-09       Impact factor: 3.225

8.  Development of a multiple-drug delivery implant for intraocular management of proliferative vitreoretinopathy.

Authors:  T Zhou; H Lewis; R E Foster; S P Schwendeman
Journal:  J Control Release       Date:  1998-11-13       Impact factor: 9.776

9.  Compression behaviour of the enzyme beta-galactosidase and its mixture with microcrystalline cellulose.

Authors:  Tanja Kuny; Hans Leuenberger
Journal:  Int J Pharm       Date:  2003-07-09       Impact factor: 5.875

10.  The relationship between the glass transition temperature and water vapor absorption by poly(vinylpyrrolidone)

Authors:  C A Oksanen; G Zografi
Journal:  Pharm Res       Date:  1990-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.